The Sleep, Cancer and Rest (SleepCaRe) Trial: Rationale and design of a randomized, controlled trial of cognitive behavioral and bright light therapy for insomnia and fatigue in women with breast cancer receiving chemotherapy.

Author: AlexanderMarliese, BeiBei, BoyleFrances, DayDaphne, DiggensJustine, FrancisPrudence A, FtanouMaria, GarlandSheila N, LopezVeronica Aedo, MaccoraJordan, MortimerDuncan, PhillipsAndrew J K, StaffordLesley, WallaceRebecca, WhiteMichelle, WileyJoshua F

Paper Details 
Original Abstract of the Article :
Insomnia and fatigue symptoms are common in breast cancer. Active cancer treatment, such as chemotherapy, appears to be particularly disruptive to sleep. Yet, sleep complaints often go unrecognised and under treated within routine cancer care. The abbreviated delivery of cognitive behavioral therapy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.cct.2022.106877

データ提供:米国国立医学図書館(NLM)

SleepCaRe Trial: Addressing Insomnia and Fatigue in Breast Cancer Patients

Breast cancer treatment can be a challenging journey, and patients often experience a range of side effects. Insomnia and fatigue are common, and the Sleep, Cancer and Rest (SleepCaRe) Trial aims to address these issues with innovative therapies. This randomized, controlled trial investigates the efficacy of cognitive behavioral therapy for insomnia (CBTI) and bright light therapy (BLT) in women with breast cancer receiving chemotherapy.

The researchers recognize the importance of addressing sleep disturbances in cancer patients, noting that these symptoms often go undertreated. They propose that CBTI and BLT may offer accessible and cost-effective solutions for improving sleep in this population. The trial is designed to evaluate the impact of these therapies on insomnia and fatigue, providing valuable insights for improving cancer care.

Improving the Quality of Life for Breast Cancer Patients

The SleepCaRe Trial addresses a critical need for better sleep management in breast cancer patients. By exploring the effectiveness of CBTI and BLT, the researchers aim to improve sleep quality, reduce fatigue, and ultimately enhance the overall well-being of these individuals.

Navigating the Challenges of Cancer Treatment

This trial underscores the importance of a holistic approach to cancer care, considering not just the physical aspects of treatment but also the psychological and emotional well-being of patients.

Dr. Camel's Conclusion

The SleepCaRe Trial provides a valuable contribution to improving the quality of life for breast cancer patients. The researchers' focus on addressing insomnia and fatigue through innovative therapies highlights the importance of a comprehensive approach to cancer care, encompassing both physical and psychological needs.

Date :
  1. Date Completed 2022-09-23
  2. Date Revised 2022-10-18
Further Info :

Pubmed ID

35961468

DOI: Digital Object Identifier

10.1016/j.cct.2022.106877

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.